News center | Philippines​

Sep 28, 2020

In celebration of World Heart Day (Sep 29): How Image-Guided Therapy can provide the best patient care for cardiovascular patients

Manila, Philippines – Across the globe, cardiovascular disease (CVD) continues to take many lives, as it is the main cause of the death for about 17.7 million people each year1. In the Philippines, coronary heart disease is the cause of 19.83% of total deaths, making it the leading cause of death for Filipinos2. With the current COVID-19 pandemic, CVD patients are posed with an even greater threat as they are more at risk for developing more severe forms of the virus3. Since the pandemic started, we have been continuously learning about the relationship between COVID-19 and cardiovascular health.


Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, continues to innovate on new approaches to health and healthcare in order to improve the overall experience and quality of life for patients. In celebration of World Heart Day on September 29, Philips aims to educate on how image-guided therapy (IGT) can provide the needed support for healthcare institutions and professionals to give best care for their CVD patients.

Philips’ IGT cardiology solutions such as the Philips Azurion 3 F12, Azurion 7 C12 and Azurion biplane B12/12, has advanced the art of minimally invasive procedures for patients with CVD. As diseases such as coronary artery diseases become more complex, the medical community seeks ever more precise, accurate and efficient tools in order to decide, guide, treat, and confirm the right therapy for the right patient at the point of care4. The aim is to save and improve lives while reducing the total cost of care through more efficient, more appropriate, and more personal therapies5.


As new challenges emerge in the space of cardiovascular health, Philips aims to help understand and meet patients evolving needs with new solutions backed by clinical evidence. With its portfolio of advanced diagnostic and specialized treatment solutions, Philips aims to support healthcare professionals and institutions in improving workflow processes. With these solutions, our healthcare workers can decide, guide, treat, and confirm the right therapy for each patient at the point of care6.

Decide, Guide, Treat, and Confirm: Optimizing Coronary Medical Procedures

At the point of decision, Philips’ physiology and imaging devices, such as the Philips IntraSight, help HCPs decide which patients need treatment, as well as the most appropriate therapy for them. By making the right decision from the beginning, HCPs are able to streamline and optimize the medical process, thereby ensuring a smooth and efficient procedure.


Applications such as Dynamic Coronary Roadmap helps HCPs guide the patients’ treatment with Philips’ coronary imaging catheters providing more data to ensure precision in making lesions. Azurion’s 12-inch detectors’ high-resolution imaging over a large field-of-view (FOV) helps HCPs visualize the entire coronary tree in a single view with same full projection flexibility9. It is crucial especially during this time of patient influx for HCPs to minimize errors in medical procedures in order to deliver the best patient care.


During treatment, Philips’ devices such as Refinity and the ELCA coronary laser atherectomy catheter ensure a user-friendly experience for healthcare practitioners as these solutions help them cross, prepare, and treat even with the most complex cases. Philips is the only company that can do digital and rotational IVUS10. With specialized technologies that are easy to use, medical workers are able to effectively and efficiently improve their workflow processes.


Finally, the physiology data from Philips IGT solutions such as IVUS help confirm the effectiveness of the treatment in creating potentials for the best patient outcomes. When given the most effective and personalized treatment, patients will be able to recover and have a good quality of life after7.


Providing the best care for CVD patients through IGT solutions

As many Filipinos continue to struggle with CVD, it is important for our healthcare systems to provide them with the care that they need. The primary objective of every healthcare professional or institution is to get patients back to living their regular lives. At Philips, the purpose of its IGT cardiovascular solutions is to help them achieve that objective – quicker8.


“We are very passionate about continuously innovating in order to make our work meaningful and helpful for everyone. This World Heart Day, as we unite to battle against CVD and other health risks, we aim to work together to treat every patient like family in order to ensure that they will not only recover, but to ensure that they get the best quality of life,” said Ashwin Chari, country manager, Philips Philippines, Inc.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at

Click here to read moreClick here to read less



Sheo Rai

Sheo S. Rai

Senior Manager
Brand and Communications
Philips ASEAN Pacific

Media assets

How Image-Guided Therapy can provide the best patient care for cardiovascular patients

Share on social media

You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.